These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1352745)

  • 1. Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
    Ruuska PE; Ikäheimo I; Silvennoinen-Kassinen S; Käär ML; Tiilikainen A
    Clin Exp Immunol; 1992 Jul; 89(1):18-21. PubMed ID: 1352745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of CR1 (the C3b complement receptor, CD35) expression on erythrocytes of HIV-infected individuals.
    Cohen JH; Geffriaud C; Caudwell V; Kazatchkine MD
    AIDS; 1989 Jun; 3(6):397-9. PubMed ID: 2568845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon.
    Kumar A; Malaviya AN; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Res; 1994; 13(1):61-71. PubMed ID: 7897264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
    Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
    J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
    Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion.
    Cornillet P; Philbert F; Kazatchkine MD; Cohen JH
    J Immunol Methods; 1991 Feb; 136(2):193-7. PubMed ID: 1671871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
    Yuan YD; Zhao MX; Yu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism.
    Mitchell JA; Sim RB; Sim E
    Clin Exp Immunol; 1989 Dec; 78(3):354-8. PubMed ID: 2575471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes.
    Wilson JG; Murphy EE; Wong WW; Klickstein LB; Weis JH; Fearon DT
    J Exp Med; 1986 Jul; 164(1):50-9. PubMed ID: 3014040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus.
    Ruuska P; Ilonen J; Mustonen A; Tiilikainen A
    Clin Exp Immunol; 1984 Jul; 57(1):12-6. PubMed ID: 6235073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired loss of erythrocyte complement receptor type 1 in patients with diabetic nephropathy undergoing hemodialysis.
    Wakabayashi M; Ohi H; Tamano M; Onda K; Fujita T; Tomino Y
    Nephron Exp Nephrol; 2006; 104(3):e89-95. PubMed ID: 16837818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus.
    Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G
    Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The structure and role of CR1 complement receptor in physiology].
    Rochowiak A; Niemir ZI
    Pol Merkur Lekarski; 2010 Jan; 28(163):79-83. PubMed ID: 20369732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus.
    Cornillet P; Gredy P; Pennaforte JL; Meyer O; Kazatchkine MD; Cohen JH
    Clin Exp Immunol; 1992 Jul; 89(1):22-5. PubMed ID: 1352746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestations.
    Feinberg BB; Jack RM; Mok SC; Anderson DJ
    Am J Reprod Immunol; 2005 Dec; 54(6):352-7. PubMed ID: 16305660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility.
    Rowe JA; Raza A; Diallo DA; Baby M; Poudiougo B; Coulibaly D; Cockburn IA; Middleton J; Lyke KE; Plowe CV; Doumbo OK; Moulds JM
    Genes Immun; 2002 Dec; 3(8):497-500. PubMed ID: 12486610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).
    Cohen JH; Lutz HU; Pennaforte JL; Bouchard A; Kazatchkine MD
    Clin Exp Immunol; 1992 Mar; 87(3):422-8. PubMed ID: 1531948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease.
    Mahmoudi R; Feldman S; Kisserli A; Duret V; Tabary T; Bertholon LA; Badr S; Nonnonhou V; Cesar A; Neuraz A; Novella JL; Cohen JHM
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects.
    Katyal M; Tiwari SC; Kumar A; Dinda AK; Arora V; Kumar R; Das N
    Mol Immunol; 2004 Apr; 40(18):1325-32. PubMed ID: 15072851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1.
    Moulds JM; Moulds JJ; Brown M; Atkinson JP
    Vox Sang; 1992; 62(4):230-5. PubMed ID: 1379395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.